Reuters logo
BRIEF-Genmab raises 2016 financial guidance
February 6, 2017 / 6:02 AM / 10 months ago

BRIEF-Genmab raises 2016 financial guidance

Feb 6 (Reuters) - Genmab A/S :

* Raises its 2016 financial guidance published on Dec. 20, 2016

* Expects FY revenue of 1.79 billion Danish crowns - 1.84 billion Danish crowns ($259.43 million-$266.67 million) against previous guidance of 1.72 billion-1.77 billion crowns

* Expects FY operating income of 1.02 billion crowns - 1.07 billion crowns against previous guidance of 895 million-945 million crowns

* Says revenue range increased primarily due to higher royalties on net sales of DARZALEX by Janssen and achievement of additional DuoBody milestones Source text for Eikon: Further company coverage: ($1 = 6.8998 Danish crowns) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below